MEDx Demo License Medical Usage Restrictions Agreement
Please read this statement of usage restrictions before using the MEDx
demo. Since the MEDx demo is time-limited, you will not be required to
sign and returen the full MEDx usage restrictions form.
We wish to thank you for your past support and continued usage of the
MEDx medical image visualization and analysis program for UNIX workstations.
We have many future plans for the product, and we will advise you through
the appropriate channels as these enhancements become available.
At the same time, however, we wish to remind you that the MEDx product
is "for research use only" or "for investigational use
only." The Department of Health and Human Services (DHHS) National
Institute of Health (NIH) defines "research" as...
" ... a systematic investigation, including research development,
testing and evaluation, designed to develop or contribute to generalizable
knowledge... " (Cf. 45 CFR 46.102(d))
The "human subject" in research is...
" ... a living individual about whom an investigator... conducting
research obtains (1) data through intervention or interaction with the
individual, or (2) identifiable private information. Intervention includes
both physical procedures by which data are gathered and manipulations
of the subject or the subject’s environment that are performed for research
purposes. Interaction includes communication or interpersonal contact
between the investigator and subject... " (Cf. 45 CFR 46.102(f))
Similarly, the DHHS Food and Drug Administration (FDA) defines an "investigation"
as...
"... a clinical investigation or research involving one or
more subjects to determine the safety or effectiveness of a device...
" (Cf. 21 CFR 812.3(h))
The FDA definition of a "subject" is...
" ... a human who participates in an investigation, either
as an individual on whom... an investigational device is used or as
a control. A subject may be in normal health or may have a medical condition
or disease... " (Cf. 21 CFR 812.3(p))
Within this regulatory framework, then, a clinical investigation can
be argued to be a more restrictive form of research, in which the data
and information collected are intended to be used to support the claims
of a device's safety or effectiveness (the FDA regards software used in
medical applications to be a medical device).
At the present time, Medical Numerics makes no representation that the
MEDx product is either safe or effective for any intended use for which
research may currently be performed.
If you are conducting research or clinical investigations, then by law
you are required to obtain prior Investigational Review Board (IRB) approval
of the clinical study protocol and of the patient informed consent documents,
and to provide each patient/subject with a copy of the completed informed
consent document. Similarly, if you are conducting research or clinical
investigations using animal subjects, you are obligated to follow Good
Laboratory Practices, and to observe the ethical treatment of the animals.
If your facility or academic institution receives funding from NIH, or
if your IRB has DHHS-approved assurances on file, then you are obligated
to follow the NIH rules, in addition to the FDA rules.
As a consequence of the regulatory status of the MEDx product, you are
reminded of the Login Acceptance Screen, reprinted below, in which you
acknowledge the regulatory status of the product prior to using its functionality:
|
*************************************************
Disclaimer: MEDx IS NOT FOR CLINICAL USE.
*************************************************
MEDx, or data derived from MEDx, may be used only for research
and may not under any circumstances whatsoever be used for clinical
purposes. Pressing the 'Accept' button below indicates your consent
NOT to use MEDx for anything other than research purposes.
|
|
You are encouraged to contact your governing IRB or clinical risk manager
should you have any additional questions or concerns. We hope that this
information clarifies your understanding of the regulatory status of the
MEDx product, and look forward to continued dialog with you.
To acknowledge the conditions regulating the use of MEDx, please sign
this letter in the space provided below and fax a copy to us at (703)
437-1725.
We wish you continued success in your research activities.
Top
|